Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2009-04-30
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.
NCT03680066
Phenotypical Characterization of Peanut Allergic Children
NCT02961452
Predictors of Positive Food Challenge
NCT02786914
Assessing Risk of Food Insecurity Within Households of Children With Food Allergy
NCT01897506
Integrated Approaches to Food Allergen and Allergy Risk Management
NCT02295397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A questionnaire pertaining to their TN allergy will be administered
A brief physical exam will be performed.
Skin prick tests using selected nut allergen extracts along with a positive (histamine) and a negative (salt-water) control will be performed at the first oral food challenge visit.
Each food challenges will be performed to 1 to 3 TNs.
Two telephone follow-up phone calls will evaluate inclusion/exclusion of tree nuts in the diet post food challenge.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has current serum IgE test within the past 12 months to major nuts in question. All TN serum IgE are \<10
* Children must have a stable baseline examination prior to undergoing challenge without significant symptoms of atopic dermatitis, allergic rhinoconjunctivitis, current urticaria or other allergic symptoms deemed important by the physician.
* Children must have stable asthma and no wheezing or repetitive cough prior to challenge, nor have been treated with oral steroids for a significant asthma exacerbation within 1 month of challenge. Asthmatics that undergo lung function testing.
* Children must have no current illness (e.g., fever or viral illness) at time of challenge.
* The subject will be asked to restrict the use of antihistamines (short acting, 72 hours: long acting, 5-7 days), (B-agonists (12 hours), theophylline (12 hours), and cromolyn (12 hours) prior to the first mixed TN food challenge. Other medications may be continued.
Exclusion Criteria
* Life-threatening reaction (respiratory involvement requiring medications, or shock, or gastrointestinal reaction requiring intravenous fluids) to any TN.
* History of a reaction in the past year or severe reaction in the past 2 years or a history of a severe reaction anytime with a TN serum IgE \>5
* Unstable asthma, gastrointestinal disease, cardiovascular disease, chronic lung disease, beta-blocker use.
3 Years
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arkansas Children's Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stacie M Jones, MD
Role: PRINCIPAL_INVESTIGATOR
University of Arkansas for Medical Sciences / Arkansas Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
110035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.